Calendar

Week of Jan 30, 2012

Jan 30, 2012approval5326d agoAMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approvalamoxicillin

Sponsor: SANDOZ INC. Form: FOR SUSPENSION. Route: ORAL

Jan 30, 2012approval5326d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

Jan 31, 2012approval5325d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

Jan 31, 2012approval5325d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

Jan 31, 2012approval5325d agoGLEEVEC (IMATINIB MESYLATE) — FDA approvalImatinib Mesylate Shilpa

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

Jan 31, 2012approval5325d agoSOJOURN (SEVOFLURANE) — FDA approvalSEVOFLURANE

Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION

Jan 31, 2012approval5325d agoVYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL

Feb 1, 2012approval5324d agoCOSOPT PF (DORZOLAMIDE HYDROCHLORIDE) — FDA approvalCosopt

Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

Feb 1, 2012approval5324d agoIMPLANON (ETONOGESTREL) — FDA approvaletonogestrel CR

Sponsor: ORGANON. Form: IMPLANT. Route: IMPLANTATION

Feb 3, 2012approval5322d agoTIZANIDINE HYDROCHLORIDE — FDA approvalTIZANIDINE HYDROCHLORIDE

Sponsor: APOTEX INC. Form: CAPSULE. Route: ORAL

Feb 4, 2012approval5321d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL